WI 38 VA13 subline 2RA Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The WI-38 VA13 subline 2RA, derived from the historic WI-38 cell line originally sourced from the lung tissue of a 3-month-old fetus, represents a key advancement in cell culture technology. The original WI-38 cell line was crucial in developing vaccines for numerous viral diseases, such as measles, mumps, rubella, and hepatitis A. The VA13 subline 2RA is an immortalized variant of this cell line, achieved through transformation with Simian Virus 40 (SV40), a practice common in the development of immortal cell lines which allows for indefinite cell replication beyond the standard senescence point of about 50 population doublings. The incorporation of SV40 into the WI-38 cells to create the VA13 subline 2RA extends the cells' lifespan, providing a more durable model for long-term experiments. This transformation maintains the fundamental properties of the original diploid cells but alters their lifecycle and growth patterns, enabling sustained growth and facilitating extensive studies that were not possible with the finite lifespan of the parent cell line. This makes the VA13 subline particularly useful in ongoing and extensive research areas, including virology, pharmacology, and genetic research, where extended observation periods are necessary. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Synonyms | WI 38 VA-13 subline 2RA, WI 38VA13 subline 2RA, WI-38 VA13 sub 2 RA, WI38-VA13 subline 2RA, WI38 VA13/2RA, WI38VA13/2RA, VA13 2RA, WI-38 VA13, WI 38 VA 13, WI38-VA13, WI38/VA13, WI38VA13, VA-13, VA13, AG07217, AG7217 |
Characteristics
| Age | 3 months gestation |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Cell type | Fibroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | WI 38 VA13 subline 2RA (Cytion catalog number 300421) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2759 |
Biomolecular Data
| Isoenzymes | G6PD, B |
|---|---|
| Viruses | Contains Papovavirus |
| Virus susceptibility | Herpes simplex, vesicular stomatitis (Indiana), poliovirus 2 |
| Reverse transcriptase | Negative |
| Karyotype | Hyperdiploid, Modal number: 73-78 |
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | 1 to 2 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300421-300525 | Certificate of Analysis | 18. Aug. 2025 | 300421 |
| 300421-050523 | Certificate of Analysis | 23. May. 2025 | 300421 |